Yi Hsiung Chen

Yi Hsiung Chen is currently Chairman at Chia-Ho Co., Ltd., Chi-Chi Co. Ltd., Chia He Investment Co. Ltd., and Merit Ocean Biotech, Inc. Current roles also include Director at Ho Tung Chemical Corp.
since 2008, Director at CytoPharm, Inc. since 2011, Independent Director at Pharmigene, Inc. since 2020, Director at Ya Tung Investment Co. Ltd., Director at Hakers Enterprise Co. Ltd. since 2020, Independent Director at Eden Biologics, Inc. since 2015, Director at Yurun Merit Biotech (Lianyungang) Co. Ltd., Director and General Manager at Yuan.
He Biotech Co. Ltd., and Director at Chenergy Co. Ltd. Former positions include Chairman, Investor Relations Contact, and Spokesman at Merit Biotech, Inc., Chairman and General Manager at Vita Genomics, Inc., Director-Celera Genomics Group at PE Corp.
(New York), Director at Shanghai GeneCore BioTechnologies Co., Ltd., Director at Development Center for Biotechnology, Independent Director at Polaris Group, Senior Scientist at Genentech, Inc. from 1980 to 1992, Principal at Celera Group, and Member at National Institutes of Health.
Education includes a doctorate from Kent State University (Ohio) and an undergraduate degree from National Taiwan University.